Efficacy studies on a canarypox-rabies recombinant virus.
Vaccine
; 9(3): 190-3, 1991 Mar.
Article
in En
| MEDLINE
| ID: mdl-2042391
Recombinant avipox viruses have been developed expressing the rabies glycoprotein gene. A fowlpox-rabies recombinant has previously been shown to be protective against live rabies virus challenge in a number of non-avian species. This report describes the development of a canarypox-rabies recombinant. A comparison is made of the protective efficacy of this recombinant with other pox-rabies recombinants.
Search on Google
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Poxviridae
/
Rabies
/
Rabies virus
/
Viral Vaccines
Limits:
Animals
Language:
En
Journal:
Vaccine
Year:
1991
Document type:
Article
Country of publication:
Netherlands